How much can Regorafenib be reimbursed after entering medical insurance?

Regorafenib（Regorafenib）The original drug has been launched in China and has entered the scope of Class B medical insurance. The medical insurance reimbursement conditions are limited to second-line treatment of hepatocellular carcinoma and transplantation. Patients who are not eligible for third-line treatment of metastatic colorectal cancer and third-line treatment of gastrointestinal stromal tumors need to pay for it at their own expense. Different regions have different reimbursement ratios, and the price after reimbursement is different. SpecificationsThe price of each box of 40mg*28 tablets is around RMB 5,000. RegofenibThe original drug has also been launched overseas, and the Turkish version of the specification40mg*28 tablets is priced around RMB 6,400 per box (the price may fluctuate due to exchange rates).